Despite sector woes, this biotech surging: Cramer
May 22, 2014 at 18:16 PM EDT
Although the sector has fallen out of favor, there's a biotech stock trading at a 52-week high. The price action has captured Cramer's attention.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.